Company Filing History:
Years Active: 1994
Title: **Amrat Patel - Innovator in Dopamine Transporter Research**
Introduction
Amrat Patel, an accomplished inventor based in Baltimore, MD, is making significant strides in the field of neuroscience through her work on dopamine transporters. With a strong focus on the development of innovative diagnostic tools, Patel's contributions hold great potential for advancements in medical research and treatment applications.
Latest Patents
Patel holds a patent for "CDNA encoding a dopamine transporter." This invention relates to a cloned cDNA encoding the dopamine transporter protein usually found in certain neural cells. The patent further details the purified dopamine transporter protein and its applications as a biosensor material and immunogen for producing anti-DAT1 antibodies. This research also includes methodologies for using the cDNA in diagnostic and therapeutic settings and for employing permanent cell lines transformed with the dopamine transporter cDNA in pharmaceutical screening. Additionally, the use of anti-DAT1 antibodies as a diagnostic tool is addressed, reflecting the multifaceted nature of her invention.
Career Highlights
Patel's career is marked by her engagement with the United States of America as represented by the Department of Health, where she applies her research to significant health-related issues. Through her work, she aims to improve diagnostic techniques and facilitate better treatment options for various conditions linked to dopamine dysfunction.
Collaborations
In her journey, Patel has collaborated with notable colleagues such as George R. Uhl and Michael J. Kuhar. These partnerships have enriched her research experience and have contributed to the broader scientific community's understanding of dopamine transporters and their implications in health and disease.
Conclusion
Amrat Patel is a pioneering inventor whose work focuses on the critical role of dopamine transporters in neural health. Her patent reflects not only her innovative spirit but also her commitment to advancing the field of neuroscience. With continued collaboration and research, Patel's contributions may lead to significant breakthroughs in diagnosing and treating conditions related to dopamine dysfunction.